Wellnex Life's Investor Highlights - Corporate Showcase Interview

Hear Zack Bozinovski, Managing Director of Wellnex Life outline the company story, investor highlights and the strategy over the next 6 to 12 months.

 


Investor Highlights:

  • 100%-owned pharmaceutical brands - Mr. Bright, Wakey Wakey, Nighty Night, The Iron Company Pharmacy Own ranges in all major Pharmacy and Grocery retailers.
  • IP-Licensing and contract manufacturing agreements with Haleon (formerly known as GlaxoSmithKline) to use Wellnex’s intellectual property (Dossier) for soft-gel analgesic product range in Australia and New Zealand, which recently has been expanded to the UK, Ireland and UAE.
  • Two Joint Ventures with Chemist Warehouse for Australia’s first liquid paracetamol soft gel range under Wagner Health Liquigesics and the launch of Medicinal Cannabis products under the SAS-B market.
  • Growing portfolio of Intellectual Property to support new innovative product launches.
  • Growing revenue and increasing margins with revenue growing 51% in FY23 compared to FY22 and budgeted to grow a further 68% in FY24 putting the Company on pathway to profitability. 

To learn more about Wellnex Life or access investor opportunities, register your interest below.